MENU
+Compare
NUWE
Stock ticker: NASDAQ
AS OF
Aug 15 closing price
Price
$5.54
Change
-$0.12 (-2.12%)
Capitalization
38.53M

NUWE Nuwellis Inc Forecast, Technical & Fundamental Analysis

Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems... Show more

NUWE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for NUWE with price predictions
Aug 15, 2025

NUWE's RSI Indicator ascending out of oversold territory

The RSI Oscillator for NUWE moved out of oversold territory on August 14, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 56 similar instances when the indicator left oversold territory. In of the 56 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 14 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where NUWE advanced for three days, in of 202 cases, the price rose further within the following month. The odds of a continued upward trend are .

NUWE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 30, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on NUWE as a result. In of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for NUWE turned negative on August 04, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NUWE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for NUWE entered a downward trend on August 14, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.256) is normal, around the industry mean (59.359). P/E Ratio (0.009) is within average values for comparable stocks, (38.307). NUWE's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.709). NUWE has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.020). P/S Ratio (0.044) is also within normal values, averaging (77.214).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. NUWE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NUWE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
NUWE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a developer of heart assist devices

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
12988 Valley View Road
Phone
+1 952 345-4200
Employees
59
Web
https://www.nuwellis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMGN296.476.18
+2.13%
Amgen
PAHC30.670.10
+0.33%
Phibro Animal Health Corp
CFLT17.79-0.06
-0.34%
Confluent
AMBI4.90-0.02
-0.41%
Ambipar Emergency Response
SNAL0.98-0.02
-1.51%
Snail

NUWE and Stocks

Correlation & Price change

A.I.dvisor tells us that NUWE and PRE have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NUWE and PRE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUWE
1D Price
Change %
NUWE100%
-1.77%
PRE - NUWE
24%
Poorly correlated
-1.17%
TMDX - NUWE
23%
Poorly correlated
-1.69%
HBIO - NUWE
23%
Poorly correlated
+8.09%
CRL - NUWE
22%
Poorly correlated
+0.56%
EMITF - NUWE
22%
Poorly correlated
N/A
More

Groups containing NUWE

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUWE
1D Price
Change %
NUWE100%
-1.77%
Medical/Nursing Services
industry (227 stocks)
13%
Poorly correlated
-0.81%
Health Services
industry (441 stocks)
11%
Poorly correlated
-0.03%